Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) rose 8.2% during mid-day trading on Thursday . The company traded as high as $185.33 and last traded at $186.65. Approximately 62,217 shares were traded during trading, a decline of 64% from the average session volume of 172,757 shares. The stock had previously closed at $172.45.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the company. Zacks Research upgraded Nutex Health to a "hold" rating in a research note on Monday, June 29th. Lake Street Capital reiterated a "buy" rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday. B. Riley Financial started coverage on Nutex Health in a report on Friday, June 26th. They issued a "buy" rating and a $290.00 target price for the company. Weiss Ratings raised shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, July 28th. Finally, Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Monday, July 20th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $268.33.
Read Our Latest Stock Report on Nutex Health
Nutex Health Stock Performance
The stock has a 50-day simple moving average of $160.24 and a 200 day simple moving average of $129.58. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company has a market capitalization of $1.29 billion, a PE ratio of 7.41 and a beta of 0.24.
Institutional Investors Weigh In On Nutex Health
Several institutional investors and hedge funds have recently made changes to their positions in NUTX. Kilter Group LLC purchased a new position in Nutex Health during the 2nd quarter valued at about $27,000. Islay Capital Management LLC acquired a new stake in shares of Nutex Health in the fourth quarter valued at approximately $34,000. Allworth Financial LP acquired a new stake in shares of Nutex Health in the second quarter valued at approximately $35,000. BNP Paribas Financial Markets increased its stake in shares of Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock worth $40,000 after purchasing an additional 290 shares in the last quarter. Finally, Royal Bank of Canada raised its position in shares of Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company's stock worth $59,000 after purchasing an additional 316 shares during the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
About Nutex Health
(
Get Free Report)
Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
